Cannabisplatz: A game-changing platform for cannabis therapy in Germany?

By |2023-09-29T15:43:14+01:0029 September 2023|

In the ever-evolving landscape of healthcare, innovations are constantly emerging to improve patient care and quality of life. One such groundbreaking start-up is Cannabisplatz, an online platform designed to offer safe and secure access to medical cannabis treatments in Germany. Cannabisplatz is an innovative online platform [...]

Comments Off on Cannabisplatz: A game-changing platform for cannabis therapy in Germany?

Cannabis-in-brief: The Netherlands, Portugal and Belgium look towards reform while France casts doubt on medical access

By |2023-09-29T15:42:53+01:0029 September 2023|

We look back at the developments over the last two weeks to bring you some of the headlines you might have missed. The top lines: The Netherlands has announced an official start date for its legalisation pilot, while officials in Portugal and Belgium also appear to [...]

Comments Off on Cannabis-in-brief: The Netherlands, Portugal and Belgium look towards reform while France casts doubt on medical access

Are social clubs the way forward for cannabis reform?

By |2023-09-29T15:42:31+01:0029 September 2023|

Research suggests that cannabis social clubs play a key role in future legislation reform and can be effective in achieving social justice for those affected by prohibition.  A gradual shift is taking place across the globe, as more and more jurisdictions look to address the failings [...]

Comments Off on Are social clubs the way forward for cannabis reform?

Australian cannabis clinic AlternaLeaf launches in UK

By |2023-09-29T15:42:14+01:0029 September 2023|

The Australian clinic, which is said to have helped hundreds of thousands of patients access medical cannabis, is now launching in the UK. AlternaLeaf, a private clinic which has been prescribing cannabis medicines across Australia, is now open to patients in the UK. The announcement comes [...]

Comments Off on Australian cannabis clinic AlternaLeaf launches in UK

The Gold Standard for Accurate Cannabinoid Products – PhytoVista Laboratories Joins Forces With BRITISH CANNABIS™

By |2023-09-28T03:09:42+01:0028 September 2023|

With the acquisition of a leading scientific cannabinoid testing facility, BRITISH CANNABIS takes its track record for having the most rigorously tested CBD products in the market and amplifies it tenfold. This can strengthen confidence that consumers and business partners have in the reliability of cannabinoid [...]

Comments Off on The Gold Standard for Accurate Cannabinoid Products – PhytoVista Laboratories Joins Forces With BRITISH CANNABIS™

French government will not propose medical cannabis legalisation in 2024

By |2023-09-28T03:09:20+01:0028 September 2023|

Via Newsweed New information suggests that the Macron government will not support the general legalisation of medical cannabis in France when the ongoing trial ends in 2024. French media outlet Newsweed reports that the future Social Security Financing Bill (PLFSS) will not include a budget for [...]

Comments Off on French government will not propose medical cannabis legalisation in 2024

Risk of anxiety and depression doubles when cannabis and tobacco are used together, study finds

By |2023-09-27T03:17:38+01:0027 September 2023|

A recent study has found that people who use cannabis and tobacco simultaneously are nearly twice as likely to develop symptoms of mental health, specifically anxiety and depression, than those who don’t. With the aim of adding to a perceived lack of information on the association [...]

Comments Off on Risk of anxiety and depression doubles when cannabis and tobacco are used together, study finds

Use of cannabinoids in intensive care needs ‘further exploration’ – study

By |2023-09-27T03:17:21+01:0027 September 2023|

A new study is the first to explore the role of cannabinoids in treating critically ill patients, with doctors calling for further research in this area. For the first time researchers have explored the therapeutic potential of cannabinoids in critically ill patients in intensive care. The [...]

Comments Off on Use of cannabinoids in intensive care needs ‘further exploration’ – study

Texas Takes Advantage of the 2018 Farm Bill

By |2023-09-27T03:17:06+01:0027 September 2023|

When Texas Governor Greg Abbott signed Senate Bill 339, also known as the Texas Compassionate Use Act, into law in 2015, many Texans expressed frustration. The purpose of the act was to allow the THC treatment of illness via prescription, opening up the state’s medicinal cannabis [...]

Comments Off on Texas Takes Advantage of the 2018 Farm Bill

Scientists publish new recommendations for CBD dosing

By |2023-09-26T03:20:12+01:0026 September 2023|

A new review has published recommendations for the maximum daily CBD intake, with up to 160mg found to be acceptable for ‘healthy’ adults.  The scientific review was commissioned by cannabis companies, Canopy Growth and Charlotte’s Web, to develop recommendations for oral doses of CBD isolate.  Researchers [...]

Comments Off on Scientists publish new recommendations for CBD dosing

Cannabis Lab Testing Problems Continue Nationwide

By |2023-09-26T03:20:04+01:0026 September 2023|

In Maine, a laboratory released a study they conducted, finding a 17% failure rate of dangerous pesticides in cannabis samples tested. The state requires testing for adult use cannabis, but not for medical cannabis. Just under 4% of adult use samples failed a pesticide screening, while [...]

Comments Off on Cannabis Lab Testing Problems Continue Nationwide

Thailand’s new PM threatens to clamp down on cannabis

By |2023-09-23T03:28:51+01:0023 September 2023|

The latest Prime Minister of Thailand, Srettha Thavisin, has said his government will “rectify” the country’s cannabis policy and limit its use to medical purposes within six months. In an interview with Bloomberg, Thavisin, who was elected in August, said there is a need to “rewrite [...]

Comments Off on Thailand’s new PM threatens to clamp down on cannabis

Medicinal cannabis and migraine – “It allows me to live a full life”

By |2023-09-23T03:28:29+01:0023 September 2023|

Joe* speaks to Cannabis Health about how his prescription has enabled him to live a full life despite the debilitating symptoms brought on by vestibular migraines.  Joe, 29, began experiencing vestibular migraines whilst at university. Sometimes they would last for months at a time and leave [...]

Comments Off on Medicinal cannabis and migraine – “It allows me to live a full life”

New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders

By |2023-09-22T03:04:52+01:0022 September 2023|

New research suggests cannabis may go some way to reducing the risk of developing Type 2 diabetes, while other studies shed light on its potential in fibromyalgia, autism and skin disorders. A wealth of cannabis-related research has been published over the last few months, including studies [...]

Comments Off on New cannabis research: cancer, Type 2 diabetes, autism, fibromyalgia and skin disorders

Is Portugal preparing to legalise adult-use cannabis?

By |2023-09-21T03:19:46+01:0021 September 2023|

Via Cannareporter One of Portugal’s major political parties is to establish a working group to explore the possibility of legalising cannabis for non-medical purposes, in collaboration with other parliamentary groups. The regulation of recreational cannabis in Portugal may be imminent, following the European trend to review [...]

Comments Off on Is Portugal preparing to legalise adult-use cannabis?

The Netherlands to launch cannabis legalisation pilot December 2023

By |2023-09-20T03:20:09+01:0020 September 2023|

Dutch officials have announced that the country’s cannabis legalisation experiment will begin its pilot phase before the end of the year. Initially approved by the senate in 2019, the Wietexperiment [Weed Experiment] will see a select number of cultivators permitted to supply legal cannabis to coffee [...]

Comments Off on The Netherlands to launch cannabis legalisation pilot December 2023

Endocannabinoid system could be key in treating stress-related conditions – study

By |2023-09-20T03:19:58+01:0020 September 2023|

New findings related to how the body’s endocannabinoid system responds to stress could open a new avenue of drug development to treat psychiatric disorders, say researchers.  Scientists believe that when an individual is under stress the brain may release its own cannabinoid molecules to calm them [...]

Comments Off on Endocannabinoid system could be key in treating stress-related conditions – study

Cannabis legalisation leads to drop in mental health admissions, study shows

By |2023-09-19T03:26:30+01:0019 September 2023|

Researchers in America have discovered that shortly after states changed their laws to allow for recreational cannabis use, the number of admissions into mental health treatment facilities declined.  Published in Health Economics in June 2023, the study shows that in the two years following a state’s [...]

Comments Off on Cannabis legalisation leads to drop in mental health admissions, study shows

What is CBDA? Raw cannabinoids and their potential benefits

By |2023-09-19T03:25:48+01:0019 September 2023|

While not as well-known as CBD or THC, raw cannabinoids such as cannabidiolic acid (CBDA), are becoming more popular due to their potential health and wellness benefits. The term ‘raw cannabinoids’ refers to the chemical compounds found in the cannabis plant in their natural form, before [...]

Comments Off on What is CBDA? Raw cannabinoids and their potential benefits

Lyphe Group and Boveda forge partnership for UK cannabis patients

By |2023-09-15T03:20:51+01:0015 September 2023|

UK medical cannabis company, Lyphe Group, has announced a new partnership to enhance how patients receive their cannabis prescriptions.  In what is thought to be an industry first, Lyphe Group’s dispensing pharmacy, Dispensary Green, has partnered with Boveda Inc, a global leader in two-way humidity control, [...]

Comments Off on Lyphe Group and Boveda forge partnership for UK cannabis patients

BBC documentary highlights ‘pot luck’ of access to cannabis on NHS

By |2023-09-15T03:20:37+01:0015 September 2023|

Approaching five years since medical cannabis was legalised in the UK, a new BBC documentary accuses the government of misleading the public over its availability on the NHS.  On 1 November, 2023 medical cannabis will have been legally available on prescription in the UK for five [...]

Comments Off on BBC documentary highlights ‘pot luck’ of access to cannabis on NHS

NIDA funds $3.69m study on role of genetics in response to THC

By |2023-09-15T03:20:23+01:0015 September 2023|

Researchers have received a $3.69 million grant from the National Institute on Drug Abuse (NIDA) to study how genetic differences influence behavioural and physiological responses to tetrahydrocannabinol (THC). Increased legalisation of medical and/or recreational cannabis and more favourable public perspectives has led to an increase in [...]

Comments Off on NIDA funds $3.69m study on role of genetics in response to THC

Lone Star Cannabis: What’s Holding Texas Back?

By |2023-09-15T03:20:01+01:0015 September 2023|

Adult-use cannabis has gained steam across the nation as more and more states jump on the legalization train. As of the writing of this article, 23 states have legalized adult-use while another 15 have allowed the sale of cannabis for medicinal purposes, for a total of [...]

Comments Off on Lone Star Cannabis: What’s Holding Texas Back?

Medical cannabis ‘effective’ and ‘fast-acting’ for neuropathic pain – study

By |2023-09-14T03:05:32+01:0014 September 2023|

Researchers behind a new study say medicinal cannabis is not only effective and fast-acting in the treatment of neuropathic pain, but also has fewer side-effects than conventional medicines.  A retrospective study, conducted by scientists from the University Medical Center Hamburg-Eppendorf (UKE Hamburg) in Germany in cooperation [...]

Comments Off on Medical cannabis ‘effective’ and ‘fast-acting’ for neuropathic pain – study

HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry

By |2023-09-14T03:05:22+01:0014 September 2023|

In the most unexpected development to hit the cannabis industry in years, the U.S. Department of Health and Human Services’ (HHS) Secretary Xavier Becerra shared his agency’s recommendation that, based on data and scientific analysis, cannabis, a Schedule I drug under the Controlled Substances Act, should [...]

Comments Off on HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry

CanXChange introduces revolutionary CX financing Service, redefining industry standards

By |2023-09-13T03:05:21+01:0013 September 2023|

CanXChange, the largest B2B cannabis platform in Europe and a leading financial technology company, is proud to announce the launch of its newest service, CX Financing. This innovative product is set to transform the receivables financing landscape, offering exclusive credit terms to our esteemed partners and [...]

Comments Off on CanXChange introduces revolutionary CX financing Service, redefining industry standards

“As a disabled person and full-time carer, cannabis enables me to support my partner”

By |2023-09-13T03:05:10+01:0013 September 2023|

After years of pain medication and antidepressants, Kerry Davies came off all her NHS prescription drugs when she started consuming cannabis medicinally. Here, she shares her journey so far. Kerry Davies battles daily with the symptoms of fibromyalgia and PTSD, as well as her history of [...]

Comments Off on “As a disabled person and full-time carer, cannabis enables me to support my partner”

The CBD Regulatory Environment in Europe: Part 4

By |2023-09-13T03:05:03+01:0013 September 2023|

This is the final piece of a four-part series discussing European cannabis regulations. Click here for Part One, here for Part Two and here for Part Three. Part Four wraps up the series below.  Where is the future of CBD heading? A review of these various jurisdictions, the EU, [...]

Comments Off on The CBD Regulatory Environment in Europe: Part 4

Alternatives to Bankruptcy for Cannabis Companies: Part 3

By |2023-09-13T03:05:00+01:0013 September 2023|

Part 1 of this series discussed the lack of bankruptcy protections for cannabis companies, since bankruptcy in the U.S. is an exclusively federal procedure and cannabis remains illegal under federal law and proposed a number of alternative options for businesses struggling in the current environment. Part [...]

Comments Off on Alternatives to Bankruptcy for Cannabis Companies: Part 3

Study sheds light on anti-inflammatory action of cannabinoids

By |2023-09-12T03:03:10+01:0012 September 2023|

Researchers in Germany have shed new light on how cannabinoids could potentially reduce inflammation in the body, with CBD found to be particularly effective. Friedrich-Schiller-Universitaet Jena in Germany, have been investigating how certain compounds found in the cannabis plant work to counteract inflammation in the body.  [...]

Comments Off on Study sheds light on anti-inflammatory action of cannabinoids

Cannabis-in-brief: US rescheduling, wider NHS access, Long Covid and workplace discrimination

By |2023-09-09T03:12:20+01:009 September 2023|

We bring you the news you might have missed from the week just gone. The top lines: Health officials in the US have recommended that cannabis be rescheduled to a ‘lower risk’ drug, while the UK Home Affairs Committee called for wider access to cannabis on [...]

Comments Off on Cannabis-in-brief: US rescheduling, wider NHS access, Long Covid and workplace discrimination

Switzerland’s ‘pragmatic not political’ approach to cannabis reform should set precedent

By |2023-09-09T03:12:06+01:009 September 2023|

Via Business of Cannabis  As Switzerland sees the launch of its second cannabis pilot, Cannavigia co-founder Philipp Hagenbach, shares his insights on the country’s approach to reform. Recent weeks have seen the launch of ZüriCan, Switzerland’s second cannabis pilot set to give over 2,000 Zurich inhabitants [...]

Comments Off on Switzerland’s ‘pragmatic not political’ approach to cannabis reform should set precedent

Cannabis patients are being discriminated in the workplace, report suggests

By |2023-09-08T03:12:21+01:008 September 2023|

Employers are at risk of breaching the Equality Act over their approach to prescription cannabis patients, according to a new report from the Cannabis Industry Council (CIC). The report, titled ‘The Use of Prescription Cannabis at Work’, claims that employers must provide reasonable adjustments to accommodate [...]

Comments Off on Cannabis patients are being discriminated in the workplace, report suggests

Government to make laughing gas illegal by the end of the year

By |2023-09-08T03:12:14+01:008 September 2023|

The government has this week released plans to make illegal the possession, supply and production of laughing gas, otherwise known as nitrous oxide. The gas, which is commonly used in medical practice and catering, will become a Class C drug. The new ruling means those caught [...]

Comments Off on Government to make laughing gas illegal by the end of the year

Prescription cannabis patients at risk of discrimination in the workplace, says report

By |2023-09-08T03:11:44+01:008 September 2023|

Employers may be breaching the Equality Act over their approach to prescription cannabis patients in the workplace, according to a new report. What are your rights as an employer and an employee? Published by the Cannabis Industry Council (CIC), ‘The Use of Prescription Cannabis at Work’, [...]

Comments Off on Prescription cannabis patients at risk of discrimination in the workplace, says report

Cannabis linked to improvements in fatigue and quality of life – study

By |2023-09-08T03:11:31+01:008 September 2023|

Australian patients with chronic health issues showed significant improvements in overall health-related quality of life and fatigue in the first three months of treatment with medical cannabis, a new study has found. The paper, published in the journal PLOS ONE, also noted that participants reported improvements [...]

Comments Off on Cannabis linked to improvements in fatigue and quality of life – study

How cannabis could help manage the unmet need in endometriosis

By |2023-09-07T03:14:06+01:007 September 2023|

Endometriosis is a chronic inflammatory disorder that affects 10% of all women between the ages of 12 and 80 years old and for which there is an urgent need for new treatment options. Here, experts at SOMAÍ Pharmaceuticals explore how cannabis could be part of the [...]

Comments Off on How cannabis could help manage the unmet need in endometriosis

US: Rising rates of cannabis use among older adults are ‘no surprise’

By |2023-09-07T03:13:46+01:007 September 2023|

With cannabis use reaching its highest recorded levels among older adults in the US, this generation may finally be recognising its potential enhancing health and wellbeing. Insights from a recent federally-funded survey in the US suggest that cannabis use has risen significantly in the last decade, [...]

Comments Off on US: Rising rates of cannabis use among older adults are ‘no surprise’

The CBD Regulatory Environment in Europe: Part 3

By |2023-09-07T03:13:40+01:007 September 2023|

This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part Three dives into dosage, approvals and more. Stay tuned for the final Part Four, coming next week. But does CBD harm the liver? Here, [...]

Comments Off on The CBD Regulatory Environment in Europe: Part 3

Psilocybin treats symptoms of major depression after just one dose, study shows

By |2023-09-06T03:07:43+01:006 September 2023|

A study published in the Journal of American Medicine suggests that one dose of psilocybin, the active ingredient in magic mushrooms, can have a significant positive effect on participants living with major depressive disorder.  The randomised, double-blind study was undertaken by a team of scientists from [...]

Comments Off on Psilocybin treats symptoms of major depression after just one dose, study shows

Potential of cannabis in treating Long Covid warrants further research

By |2023-09-06T03:07:13+01:006 September 2023|

The role of cannabis-based medicines in treating the symptoms of Long Covid warrants further investigation, according to a new review. UK researchers say existing evidence supports the use of cannabis as a potential treatment for Long Covid, including for symptoms of sleep disturbance, fatigue, pain and [...]

Comments Off on Potential of cannabis in treating Long Covid warrants further research

Congress Wants YOU To Make Safe Products.

By |2023-09-06T03:06:47+01:006 September 2023|

Recently, Congress requested detailed information regarding the regulation of CBD and other cannabinoids. This comes on the heels of frustration around federal inaction with regards to cannabinoid-containing products produced from Cannabis sativa L. plant extracts that can be classified as “hemp” products amidst the clear need [...]

Comments Off on Congress Wants YOU To Make Safe Products.

Are disposable CBD vapes bad for the environment?

By |2023-09-05T03:18:10+01:005 September 2023|

Vaping is a popular way of consuming CBD, but there’s a dark side to the disposable vapes which have flooded the market in recent years. As we previously explored, vaping is an increasingly popular way of administering CBD, mainly due to its fast-acting effects and its [...]

Comments Off on Are disposable CBD vapes bad for the environment?

MPs call on the government to reintroduce drug testing at festivals

By |2023-09-02T03:02:24+01:002 September 2023|

Event drug testing can prevent harm and must be reintroduced to festivals by the 2024 season, says a prominent parliamentary committee in a new report released this week.  The Home Affairs Committee released their inquiry as a response to the government’s latest drugs strategy, ‘From Harm [...]

Comments Off on MPs call on the government to reintroduce drug testing at festivals

Home Affairs Committee calls for wider NHS access to medical cannabis

By |2023-09-02T03:02:01+01:002 September 2023|

In its latest report on drugs, the UK Home Affairs Committee recommends that the government widens access to cannabis medicines on the NHS, but cites ‘concerns’ over non-medical use.  The new report, published by the Home Affairs Committee on Thursday 31 August, sets out a number [...]

Comments Off on Home Affairs Committee calls for wider NHS access to medical cannabis

Alternatives to Bankruptcy for Cannabis Companies: Part 2

By |2023-09-02T03:01:53+01:002 September 2023|

Part 1 of this series discussed the lack of bankruptcy protections for cannabis companies, since bankruptcy in the U.S. is an exclusively federal procedure and cannabis remains illegal under federal law and proposed a number of alternative options for businesses struggling in the current environment. Part [...]

Comments Off on Alternatives to Bankruptcy for Cannabis Companies: Part 2

Top US health officials recommend rescheduling cannabis

By |2023-09-01T03:00:55+01:001 September 2023|

The US Department of Health and Human Services (HHS), has recommended that cannabis be classed as a lower risk drug. Here’s what this means for research, industry and consumers. A leaked letter, seen by Bloomberg News and dated Tuesday 29 August, reveals that the HHS has [...]

Comments Off on Top US health officials recommend rescheduling cannabis